Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Trans-pulmonary Biomarkers in Pulmonary Hypertension
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Therapeutic Option for Hepatitis B and C: a French Cohort
- Status
- UNKNOWN
- Phase
- N/A
Effects of Ranolazine and Exercise on Daily Physical Activity Trial
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE2
Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Positive for Hepatitis B e Antigen
- Status
- COMPLETED
- Phase
- PHASE3
Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen
- Status
- COMPLETED
- Phase
- PHASE3
Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen
- Status
- COMPLETED
- Phase
- NA
Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Adherence, HIV-1 Infection, Resistance, and Renal and Skeletal Adverse Event in Individuals Taking Truvada® for HIV Pre-Exposure Prophylaxis (PrEP)
- Status
- COMPLETED
- Phase
- N/A
A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3